BioCentury
ARTICLE | Company News

Galapagos, GlaxoSmithKline deal

October 25, 2010 7:00 AM UTC

Galapagos received a €1 million ($1.4 million) milestone payment from GlaxoSmithKline under a 2007 deal to discover compounds against undisclosed targets for infectious diseases. The payment was trigg...